Embracing Artificial Intelligence and Machine Learning in Cancer Research and Care
The virtual AACR conference featured a panel discussion on the development of Artificial Intelligence (AI) and Machine Learning (ML) in cancer research, where speakers addressed the challenges and progress in the area. They also acknowledged the structural inequities in the healthcare system that needs to be accounted for while training algorithms for clinical care and diagnosis.
GO Prime with only $1.49 now
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23